Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The long-term objective is to further establish the role of Tysabri in preventing
neurological degeneration in multiple sclerosis (MS) and to establish powerful and efficient
new markers for neurological degeneration in MS. The study intends to correlate cognition
with two instruments and their measurements-MRI and OCT (optical coherence tomography).